symptoms of too much semaglutide Ozempic and GLP-1 Drugs: Risk Severe Side Effects Ozempic: Semaglutide is a GLP-1

The latest weight management medication on the market, Eli Lillys Foundayo (orforglipron) , was approved by the FDA in April 2026

Both excess and deficient levels of cortisol can disrupt the methylation cycle and affect the body's ability to detoxify harmful substances

The short answer is that any kind of excessive weight can lead to an increased risk for various health conditions that are known to decrease not just our life expectancy, but our healthspan as well (or, how long we stay healthy)

Another important consideration is that when the medication is discontinued, there is often weight regain

Mutation Loci of the URAT1 ( SLC22A12 ) Gene Dysfunctional variants in URAT1 are considered as the major cause of hyperuricaemia (Zhu et al., 2021)